MLchartDataset catalogue

anti-mesothelin CAR T cells UCMYM802

Term · Oncology and biomedicine · MLC-T-ONC-010882

A preparation of T lymphocytes that have been genetically modified to express a chimeric antigen receptor (CAR) specific for the human tumor-associated antigen (TAA) mesothelin (MSLN), with potential immunomodulating and antineoplastic activities. Upon administration, anti-MSLN CAR T cells UCMYM802 specifically target and kill MSLN-expressing tumor cells. MSLN, a cell surface glycoprotein involved in cell adhesion, is overexpressed in a variety of cancer cell types.

Table 1. Record
IdentifierMLC-T-ONC-010882
FieldOncology and biomedicine
Synonymsanti-MSLN CAR T cells UCMYM802; anti-mesothelin CAR-T Cells UCMYM802; anti-MSLN CAR-T cells UCMYM802
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON
{
  "id": "MLC-T-ONC-010882",
  "term": "anti-mesothelin CAR T cells UCMYM802",
  "field": "Oncology and biomedicine",
  "definition": "A preparation of T lymphocytes that have been genetically modified to express a chimeric antigen receptor (CAR) specific for the human tumor-associated antigen (TAA) mesothelin (MSLN), with potential immunomodulating and antineoplastic activities. Upon administration, anti-MSLN CAR T cells UCMYM802 specifically target and kill MSLN-expressing tumor cells. MSLN, a cell surface glycoprotein involved in cell adhesion, is overexpressed in a variety of cancer cell types.",
  "synonyms": [
    "anti-MSLN CAR T cells UCMYM802",
    "anti-mesothelin CAR-T Cells UCMYM802",
    "anti-MSLN CAR-T cells UCMYM802"
  ],
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/anti-mesothelin-car-t-cells-ucmym802/"
}

Record 2,000 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.